Found: 6
Select item for more details and to access through your institution.
The effects of single‐ and multiple‐dose administration of bococizumab (RN316/PF‐04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12309
- By:
- Publication type:
- Article
Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin.
- Published in:
- Cardiovascular Therapeutics, 2018, v. 36, n. 1, p. 1, doi. 10.1111/1755-5922.12308
- By:
- Publication type:
- Article
Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 21, p. 2516, doi. 10.1001/jama.295.21.2516
- By:
- Publication type:
- Article
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 32, doi. 10.1186/1479-5876-5-32
- By:
- Publication type:
- Article
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 1, p. 204, doi. 10.1046/j.1365-2141.2002.03717.x
- By:
- Publication type:
- Article